Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 301 - 350 of 759 results
- Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial.
- Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.
- Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction.
- Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction.
- Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction.
- Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
- Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor.
- BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
- Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction.
- Valsartan treatment reverses erectile dysfunction in diabetic rats.
- Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
- 1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.
- A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human.
- Ex vivo biomechanical properties of the female urethra in a rat model of birth trauma.
- Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold.
- Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis.
- Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
- Rapid onset of action with alfuzosin 10 mg once daily in men with benign prostatic hyperplasia: a randomized, placebo-controlled trial.
- Autoantibody-mediated bladder dysfunction in type 1 diabetes.
- Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
- The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study.
- Bidirectional relationship between depression and erectile dysfunction.
- Comparative evaluation of central muscarinic receptor binding activity by oxybutynin, tolterodine and darifenacin used to treat overactive bladder.
- Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats.
- Tadalafil for treatment of erectile dysfunction in men on antidepressants.
- Vardenafil restores erectile function to normal range in men with erectile dysfunction.
- Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
- Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire.
- High-dose atorvastatin causes regression of endometriotic implants: a rat model.
- The influence of alpha1-adrenoreceptors on neuropeptide release from primary sensory neurons of the lower urinary tract.
- Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol).
- Clozapine for the treatment of neurogenic bladder.
- 1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.
- Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
- The efficacy of duloxetine in the treatment of premature ejaculation.
- Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction.
- Botulinum toxin B is not an effective treatment of refractory overactive bladder.
- Prevalence and risk factors for erectile dysfunction in the US.
- Changes in T-type calcium channel and its subtypes in overactive detrusor of the rats with partial bladder outflow obstruction.
- Parameters of bladder function in pre-, peri-, and postmenopausal continent women without detrusor overactivity.
- Taurine ameliorates stress-induced degeneration of the urinary bladder.
- Post-marketing surveillance study of the efficacy and safety of vardenafil among patients with erectile dysfunction in primary care.
- Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function.
- A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
- Differences in alpha blocker usage among enlarged prostate patients receiving combination therapy with 5 ARIs.
- Finasteride versus dutasteride: a real-world economic evaluation.
- Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial.
- RhoA/Rho kinase-mediated Ca2+ sensitization in the contraction of human prostate.
- Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction.
- The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats.